Strategies

Incubation & Platform Companies

When we see major trends and structural changes happening in one of our core sectors, we regularly set up and invest in platform companies in order to make concentrated and focused “bets” and acquisitions. Those platform companies offer centralized services and leadership – especially centralized business development – and make most sense in the deep tech and biotech space, where founders/innovators are often amazing scientists but lack the commercial/entrepreneurial skillset.

Listed Equities & SPACs

We take active minority stakes in listed companies mainly through IPOs & SPACs, but sometimes also later in a company’s life cycle.

We offer our listed companies the same attention and value-add as we give our venture portfolio.

Apeiron is scaling one of the most comprehensive full-service SPAC teams in Europe, enhancing the desirability of Apeiron-affiliated SPACs through unique value additive capabilities and market insights.

Primarily, we are initiating and sponsoring our own SPACs – often together with strategic partners – focusing on certain high growth industries and/or regions. Additionally, we are investing into SPACs of other sponsors, offering SPAC sponsors an entrepreneurial, long-term investor & partner who not just provides capital, but also and especially deal flow.

Lead Venture Deals

Via our venture Fund Elevat3 we take active minority stakes from Series-A to Pre-IPO mainly in Europe/Germany, with Peter Thiel’s Founders Fund as strategic partner.

Global Venture Co-Investments

With our Presight Capital Fund Series we follow a very flexible, diversified approach, investing in the most ambitious founders globally at any stage, together with leading VCs.

We take pride that Presight Capital Fund ONE is one of the best performing funds of its vintage year (2019). We are known for very successful, outlier conviction bets like AbCellera, Compass Pathways and Peptilogics.

Mental Health Venture Investments

With atai Life Sciences, we have kick-started an entire industry and been a major driver of the long-deserved ‘psychedelic renaissance’ as potential treatment for various mental health issues. Around atai, an entire ecosystem is growing, from clinic operators to tech-driven therapy support.

With our venture fund re.mind we take active minority stakes from Series-A to Pre-IPO in the mental health space globally.

SpaceTech

Humans will ultimately become a spacefaring race. Until this vision becomes reality, there are a lot of attractive short term business models related to space, like building up a high-speed internet above the clouds with satellite constellations.

Europe – especially Germany - has a long tradition of real technological innovation. We try to combine Germany´s strength in innovation and technology with US-style entrepreneurship and company-building thinking when investing in European spaceTech companies.

Fund Investments

To complement and diversify our portfolio, we invest globally in hedge funds and venture capital funds. We take an entrepreneurial approach and are open to first-time funds/managers, seeding funds etc. As with our other strategies, we see ourselves as a value-add investor for our funds, providing them with our expertise and access to our network.